Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 4, July, p. 665–669

doi: 10.17219/acem/63023

PubMed ID: 28691416

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The relationship between major depressive disorder and glucose parameters: A cross-sectional study in a Chinese population

You-Fan Peng1,A,B,C,D,E,F, Shi-Mao Zhong1,B, Yu-Hua Qin1,B

1 Department of Laboratory Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China

Abstract

Background. Depressive symptoms have been linked with insulin resistance in middle-aged and elderly populations. A strong relationship between peripheral insulin resistance and glucose homeostasis imbalance has been well established in previous studies. The role of serum fructosamine and fasting blood glucose (FBG) in elevating glucose homeostasis has been documented in the literature.
Objectives. The aim of the study was to examine the association of serum fructosamine and FBG with major depressive disorder (MDD).
Material and Methods. The study analyzed the clinical characteristics and biochemical parameters of 305 patients with MDD and 312 healthy individuals.
Results. Serum concentrations of lipoprotein-cholesterol (HDL-C), total protein (TP) and creatinine (Cr) were found to be significantly different between the two groups. Serum fructosamine and fasting blood glucose (FBG) concentrations were high in patients with MDD compared with healthy individuals (2.3 ± 0.26 vs. 2.1 ± 0.27, p = 0.018; 4.7 ± 0.45 vs. 4.5 ± 0.45, p < 0.001). The levels of serum fructosamine and FBG were also significantly higher in patients with MDD when all participants were stratified by gender. Age was found to be positively correlated with FBG, serum fructosamine and Cr (r = 0.203, p < 0.001; r = 0.129, p = 0.025; r = 0.129, p = 0.024), and negatively correlated with TP (r = -0.114, p = 0.047) in patients with MDD. However, there were no correlations between age and FBG, serum fructosamine or Cr in the healthy controls. In a multivariate logistic regression analysis, increased serum fructosamine and FBG concentrations were positively associated with MDD independently of age and gender, after adjustment for age and potential confounding factors (OR = 6.313, CI95 %:2.953–13.393, p < 0.001; OR = 2.251, CI95 %: 1.464–3.462, p < 0.001).
Conclusion. The study results suggest that increased serum fructosamine and FBG concentrations are associated with depressive conditions, which may influence glucose metabolism and impair glucose homeostasis in patients with MDD.

Key words

serum fructosamine, fasting blood glucose, m DOI ajor depressive disorder

References (29)

  1. Kent S, Bluthe RM, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ. Different receptor mechanisms mediate the pyrogenic and behavioral-effects of interleukin-1. Proc Natl Acad Sci USA.1992;89:9117–9120.
  2. Sararoodi BR. Type D penonality. J Res Behav Sci. 2009;7:75–86.
  3. Topić R, Miličić D, Štimac Z, et al. Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders. Croat Med J. 2013;54:453–459.
  4. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem. 1987;33:2153e63.
  5. Peng YF, Cao WY, Zhao JM, et al. Association between serum fructosamine and kidney function in nondiabetic individuals without chronic kidney disease. Med Sci Monit. 2015;21:1996–1999.
  6. Selvin E, Francis LM, Ballantyne CM, et al. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care. 2011;34:960e7.
  7. Browner WS, Pressman AR, Lui LY, Cummings SR. Association between serum fructosamine and mortality in elderly women: the study of osteoporotic fractures. Am J Epidemiol. 1999;149:471e5.
  8. Selvin E, Rawlings AM, Grams M, et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2014;2:279e88.
  9. Sun Y, Wang C, Yang W, et al. Fasting blood glucose, but not 2-h postload blood glucose or HbA1c, is associated with mild decline in estimated glomerular filtration rate in healthy Chinese. Int Urol Nephrol. 2015;47(1):147–152.
  10. Li X, Jiang R, Kong H, Shu Y, Li Q, Hua W. Fasting blood glucose at admission and survival in patients with dilated cardiomyopathy: a single-center cohort study. Exp Clin Endocrinol Diabetes. 2014;122(8):457–462.
  11. Pan A, Ye X, Franco OH, et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: Findings from the nutrition and health of aging population in China Study. J Affect Disord. 2008;109(1–2):75–82.
  12. Rafacho A, Ortsäter H, Nadal A, Quesada I. Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes. J Endocrinol. 2014;223(3):R49-62.
  13. Tuomainen TP, Nyyssönen K, Salonen R, et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care. 1997;20(3):426–428.
  14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition. 4th edn. American Psychiatric Association: Washington, DC, 2001.
  15. Wittchen HU. Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28:57–84.
  16. Black S, Markides K, Ray L. Depression predicts increased incidence of adverse death outcomes in older Mexican-Americans with type 2 diabetes. Diabetes Care. 2003;26:2822–2828.
  17. Kinder L, Kamarck T, Baum A, Orchard T. Depressive symptomatology and coronary heart disease in type 1 diabetes mellitus. A study of possible mechanisms. Health Psychol. 2002;21:542–552.
  18. Wayne J. Katon, Elizabeth HB. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med. 200;19:1192–1199.
  19. Steptoe A. Depression and the development of coronary heart disease. In: Steptoe A, editor. Depression and physical illness. Cambridge: Cambridge University Press 2007: 53–86.
  20. Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI Jr, Newsholme P. Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid Med Cell Longev. 2015;2015:181643.
  21. Liu S, Tinker L, Song Y, Rifai N, Bonds DE. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med. 2007;167:1676–1685.
  22. Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG. Diabetes and the hypothalamo–pituitary–adrenal (HPA) axis. Minerva Endocrinol. 2003;28:87–102.
  23. Breum L, Bjerre U, Bak JF, Jacobsen S, Astrup A. Longterm effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: Influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism. 1995;44:1570–1576.
  24. Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2014;2(4):279–288.
  25. Zaccardi F1, Kurl S, Pitocco D, Ronkainen K, Laukkanen JA. Serum fructosamine and risk of type 2 diabetes mellitus among middle-age Finnish men: A 23-year population-based prospective study. Acta Diabetol. 2015;52(1):161–166.
  26. Rathmann W, Kowall B, Heier M, et al. Prediction models for incident type 2 diabetes mellitus in the older population: A cohort study. Diabet Med. 2010;27(10):1116–1123.
  27. Lieberman HR, Kellogg MD, Kramer FM, Bathalon GP, Lesher LL.Lipid and other plasma markers are associated with anxiety, depression, and fatigue. Health Psychol. 2012;31(2):210–216.
  28. Brand-Gothelf A, Leor S, Apter A, Fennig S. The impact of comorbid depressive and anxiety disorders on severity of anorexia nervosa in adolescent girls. J Nerv Ment Dis. 2014;202(10):759–762.
  29. Whited MC, Schneider KL, Appelhans BM, et al. Severity of depressive symptoms and accuracy of dietary reporting among obese women with major depressive disorder seeking weight loss treatment. PLoS One. 2014;9(2):e90361.
© Wroclaw Medical University